← Back to Screener
OmniAb, Inc. Warrant (OABIW)
Price$0.10
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (4W)6.11%
VGM Score8.26
All Metrics
Price vs S&P 500 (YTD)-24.14%
10-Day Avg Trading Volume0.02M
3-Month Avg Trading Volume0.01M
52-Week High$0.30
13-Week Price Return-58.33%
3-Month Return Std Dev298.10%
Year-to-Date Return-16.60%
5-Day Price Return-7.41%
Month-to-Date Return-14.89%
Price vs S&P 500 (13W)-67.20%
Beta1.66x
52-Week Low$0.05
mGradeF
vgmGradeF
Show chart for
Industry Peers — R&D — Physical Sciences(15)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
OABIWOmniAb, Inc. Warrant | — | — | F | $0.10 |
| IQVIQVIA Holdings Inc. | C | B | B | $186.82 |
| INCYIncyte Genomics Inc | C | A | B | $95.59 |
| MEDPMedpace Holdings, Inc. Common Stock | D | A | B | $451.47 |
| ICLRIcon Plc | C | C | B | $138.03 |
| CRLCharles River Laboratories International, Inc. | D | D | B | $182.07 |
| ABSIAbsci Corporation Common Stock | F | F | A | $6.52 |
| NRCNRC Health Common Stock | D | D | B | $20.25 |
| OABIOmniAb, Inc. Common Stock | D | C | A | $2.61 |
| MXCTMaxCyte, Inc. Common Stock | C | D | C | $1.22 |
| ONMDOneMedNet Corp Class A Common Stock | D | C | C | $0.78 |
About
OmniAb Inc develops proprietary antibody discovery technologies utilizing genetically engineered transgenic animals—OmniRat, OmniMouse, and OmniChicken—that produce fully human therapeutic antibodies optimized through in vivo affinity maturation. The company's platform enables rapid and efficient discovery of high-quality antibodies across diverse disease indications. By reducing development timelines while enhancing therapeutic quality, OmniAb accelerates the path from discovery to clinical application.